Target intelligence / Profile preview

THRB antisense RNA 1 (THRB-AS1)

Target: THRB-AS1
Molecular classification: Long noncoding RNA (lncRNA), Antisense RNA, Noncoding RNA, Natural antisense transcript (NAT)

Overview

THRB antisense RNA 1 is a long noncoding RNA molecule transcribed from the antisense strand of the thyroid hormone receptor beta (THRB) locus. As with other antisense RNAs, THRB-AS1 likely regulates gene expression by hybridizing to the complementary THRB mRNA, influencing its stability, localization, or translation into protein. Antisense RNAs play important roles in transcriptional and post-transcriptional regulation, epigenetic silencing, and activation in various biological contexts. Aberrant expression of antisense RNAs, including those similar to THRB-AS1, has been linked to cancer and other diseases through deregulation of gene expression and epigenetic modifications. While lncRNAs and antisense RNAs present opportunities for novel therapeutic strategies, THRB-AS1 itself is not a recognized therapeutic target, and direct drug interventions targeting it are not documented.

Other names: THRB-AS1THRB antisense RNA 1

Mechanism of action

No drug mechanisms are established targeting THRB-AS1 directly; antisense oligonucleotides in general may target similar lncRNAs for silencing in research and emerging therapies.

Biological functions

Regulation of gene expression (at transcriptional and post-transcriptional levels)Epigenetic regulation (can modulate chromatin structure and gene silencing/activation)May play a role in stress response and cell adaptation via regulation of mRNA transport and translation

Disease associations

Cancer (many NATs, including THRB-AS1, are dysregulated in various cancers and can regulate cancer hallmarks or act as oncogenic lncRNAs)Other roles possible, but not specifically described for THRB-AS1 in available sources

Safety considerations

No notable safety concerns specifically attributed to modulation of THRB-AS1, but altering antisense RNA function can potentially lead to off-target effects or perturb epigenetic regulation.

Beyond the preview

Go deeper on THRB antisense RNA 1 (THRB-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on THRB antisense RNA 1 (THRB-AS1).

Explore the full profile